AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
April 9, 2019

AGA seeks your comment on new ulcerative colitis guideline

Review the new moderate-to-severe ulcerative colitis guideline and its supporting materials, and share your thoughts by Wednesday, April 24.

Share on facebook
Share on twitter
Share on linkedin
Share on email

AGA is seeking public comment on a new guideline for the management of moderate to severe ulcerative colitis (UC), which addresses the medical management of adult outpatients with moderate to severe UC, as well as the medical management of adult hospitalized patients with acute severe ulcerative colitis (ASUC). This guideline focuses on immunomodulators, biologics and small molecules for induction and maintenance of remission (for moderate to severe UC) and decreasing the risk of colectomy (for ASUC). Unless otherwise specified, it does not present separate recommendations for induction and maintenance of remission.

Review and submit feedback by April 24

AGA is seeking public comment on the clinical practice guideline, clinical decision support tools and technical review for the management of moderate to severe UC. Please review the following documents:

Submit your comments by completing this survey. The public comment period ends at noon EDT on Wednesday, April 24.

Learn more about AGA’s clinical practice guidelines.

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.